Medical/Pharmaceuticals

Strekin AG Announces Completion of Patient Recruitment in the RESTORE Phase 3 Clinical Study of STR001

BASEL, Switzerland, Sept. 12, 2019 /PRNewswire/ -- Strekin AG (www.strekin.com ), a biopharmaceutical company focused on treatments for hearing loss, announced today that it has successfully completed patient recruitment in the RESTORE study, an international, randomized, ...

2019-09-12 14:15 1674

Mindray launches the new BeneHeart C Series AED to enhance resuscitation confidence

SHENZHEN, China, Sept. 12, 2019 /PRNewswire/ -- Mindray (SZSE: 300760), a global leading developer and provider of medical devices and solutions,  today launched the BeneHeart C Series automated external defibrillator (AED) with smarter operations and faster shock delivery to achieve better resus...

2019-09-12 08:00 6285

Gracell Announces Interim Readout of Investigation for First-in-class FasT CAR-19 in patients with Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia and Extension in Use of FasT CAR to Other Immune Cell Programs

SUZHOU and SHANGHAI, China, Sept. 11, 2019  /PRNewswire/ -- Gracell Biotechnologies Co., Ltd. ("Gracell"), a clinical-stage immune cell therapy company, today announced a positive continued clinical readout of a multi-center pilot study designed to evaluate the safety and efficacy of Gracell's f...

2019-09-12 05:00 1436

Gracell Announces Interim Readout of Investigation for First-in-class FasT CAR-19 in patients with Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia and Extension in Use of FasT CAR to Other Immune Cell Programs

SUZHOU and SHANGHAI, China, Sept. 12, 2019  /PRNewswire/ -- Gracell Biotechnologies Co., Ltd. ("Gracell"), a clinical-stage immune cell therapy company, today announced a positive continued clinical readout of a multi-center pilot study designed to evaluate the safety and efficacy of Gracell's f...

2019-09-12 05:00 1894

CIVCO Radiotherapy Presents Proton Head & Neck Immobilization Solution at ASTRO 2019 Annual Meeting

CORALVILLE, Iowa, Sept. 12, 2019 /PRNewswire/ -- CIVCO Radiotherapy, the leading global provider of high quality, innovative, patient-centric radiotherapy solutions, will present theirUniversal Couchtop™ proton system along with several new solutions and collaborative partnerships in booth #1814 ...

2019-09-12 04:30 1142

deCODE in Iceland Agrees to Sequence Half of UK Biobanks Participants

REYKJAVIK, Iceland, Sept. 12, 2019 /PRNewswire/ -- deCODE genetics in Iceland has entered into an agreement with a consortium of government, charity, researchers and world leading biopharmaceutical and healthcare companies to undertake whole genome sequencing of UK Biobank participants. The proje...

2019-09-12 00:25 1384

China Pharma Holdings, Inc. Has Entered into A Memorandum of Understanding With World Health Advanced Technologies, Ltd.

HAIKOU CITY, China, Sept. 11, 2019 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," "CPHI", the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced that it has entered...

2019-09-11 20:00 6427

Ossur Technologies Featured in Nature Medicine Article Reporting for the First Time on Amputees "Feeling" Their Prosthetic Foot and Knee

REYKJAVIK, Iceland, Sept. 11, 2019 /PRNewswire/ -- An article published in the journalNature Medicine reports that two above knee lower-limb amputees who had intraneural electrodes implanted in their thighs and wore Ossur prosthetic componentry are the first in the world to "feel" their prostheti...

2019-09-11 19:31 6513

China SXT Pharmaceuticals, Inc. Granted to Establish Taizhou Research Center for Advanced TCMP Engineering Techniques

TAIZHOU, China, Sept. 11, 2019 /PRNewswire/ -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces ("TCMPs"), including A...

2019-09-11 19:00 6413

Merck Announces FDA Breakthrough Therapy Designation for Investigational Therapy Tepotinib in Patients with Metastatic NSCLC with METex14 Skipping Alterations

DARMSTADT, Germany, Sept. 11, 2019 /PRNewswire/ -- Merck, a leading science and technology company, today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for the investigational targeted therapy tepotinib* in patients with metastatic non-small...

2019-09-11 14:30 1196

CIVCO Radiotherapy Expands Proton Therapy Immobilization Solutions, Releases Universal Couchtop ProForm for Head & Neck Treatment

CORALVILLE, Iowa, Sept. 10, 2019 /PRNewswire/ -- CIVCO Radiotherapy, the leading global provider of high quality, innovative, patient-centric radiotherapy solutions, today announced the release of the Universal Couchtop™ ProForm™ Head & Neck Solution, the newest development in their ProtonSeri...

2019-09-11 05:30 1093

Vision Impact Institute Expands Advisory Board

Allyala Nandakumar and Serge Resnikoff Bring Expertise in Global Health and Vision DALLAS, Sept. 11, 2019 /PRNewswire/ -- The Vision Impact Institute (VII) is pleased to announce two new additions to the organization's Global Advisory Board.Allyala Nandakumar, Ph.D, and Serge Resnikoff, M.D., Ph...

2019-09-11 02:09 1063

Internationally awarded German med-tech innovation by Syntellix now produced in Singapore for the whole of Asia

SINGAPORE, Sept. 10, 2019 /PRNewswire/ -- In the presence of the German Ambassador and the Chairman of EDB Singapore, Syntellix Asia Pte Ltd inaugurates its production site in Tuas, which hosts the first dry CNC processing of such advanced magnesium alloys inAsia. Thus, Singapore becomes the Asi...

2019-09-10 22:14 1140

Blood Cancer Experts Discuss Latest Treatment Innovations at NCCN 2019 Annual Congress: Hematologic Malignancies™

Program includes debate and interactive case studies on emerging cancer care practices.#NCCNhem19. SAN FRANCISCO, Sept. 10, 2019 /PRNewswire/ -- World-renowned experts on blood cancers are meeting inSan Francisco on September 27-28, to help clinicians stay up-to-date on new, practice-changing st...

2019-09-10 20:35 1082

KEYNOTE-024 Three-Year Survival Update: Pembrolizumab Effective as First-Line Therapy for Advanced Non-Small Cell Lung Cancer

BARCELONA, Spain, Sept. 10, 2019 /PRNewswire/ -- First-line pembrolizumab monotherapy provides durable long-term overall survival benefit compared to chemotherapy, according to data presented today by Dr. M. Reck, Lung Clinic Grosshansdorf, Airway Research Center North, Member of the German Cente...

2019-09-10 17:06 961

Doctor Anywhere Goes Regional - widens reach with signing of landmark agreement with Vietnam's most established Insurer group Bao Minh Insurance Corp.

* Singapore-based tech-led health and wellness company Doctor Anywhere signs agreement with Vietnam Insurer Bao Minh Insurance (BMI) to bring digital healthcare solutions to Vietnamese. * Users can video-consult a Vietnamese doctor on their phone and get medication delivered to them within ...

2019-09-10 12:21 1452

Insilico Medicine Secures $37M in Series B Funding Led by Qiming Venture Partners

HONG KONG, Sept. 10, 2019 /PRNewswire/ -- Insilico Medicine, a pioneer in next-generation artificial intelligence technology for drug discovery, recently completes a$37 million funding round led by Qiming Venture Partners, joined by Eight Roads, F-Prime Capital, Lilly Asia Ventures, Sinovation Ve...

2019-09-10 09:00 2513

Jubilant Life Sciences Announces Appointment of Dr. Syed Kazmi as President and CEO of its New Innovative Biopharmaceutical Company in the U.S. - Jubilant Therapeutics Inc.

YARDLEY, Pennsylvania, Sept. 9, 2019 /PRNewswire/ -- Jubilant Life Sciences Limited has announced that Dr.Syed Kazmi, PhD, MBA, will join its new innovative biopharmaceutical company in the U.S., Jubilant Therapeutics Inc., as President and Chief Executive Officer. Dr. Kazmi joins from Novartis ...

2019-09-09 22:33 1553

Lipidor Announces Enrolment of Last Patient in Calcipotriol/AKVANO Spray (AKP01) Phase III Study Targeting Psoriasis

STOCKHOLM, Sept. 9, 2019 /PRNewswire/ -- Lipidor AB (publ) today reports that the last patient has been enrolled in the ongoing phase III study using calcipotriol spray against mild to moderate psoriasis. Results from the study are expected to be presented in December 2019.  Lipidor has develope...

2019-09-09 20:37 1242

Updated Results for Investigational Therapy Tepotinib Presented at WCLC 2019

* Results include progression-free survival and overall survival data from Phase Ib/II INSIGHT study * Phase II INSIGHT 2 study now open for enrollment for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) mutation and...

2019-09-09 20:00 1330
123456 ... 344